The Inhibitory Effect of Antibody to Host Cells on Echovirus Plaques in HEp-2 Cells
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Treatment of monolayers of primary human amnion cells with homologous antiserum in sub-cytotoxic doses causes a reduction in the number of plaques formed in them by echoviruses and Coxsackievirus type A9 (Timbury, I962). Polioviruses and Coxsackieviruses of group B are virtually insusceptible to the inhibitory effect of the antiserum which is due to a reaction of the antibody with the host cells and not to direct neutralization of the virus. This report describes further investigations, in HEp-2 cells, of the virus-inhibiting action of antibody to host cells.
Antiserum to HEp-2 cells was prepared in a rabbit as described for antiserum to amnion cells (Timbury, /962). The antiserum had a titre of I/I024 in complementfixation tests with HEp-2 cells suspended in phosphate buffered saline at a concentration of 2"5 x io 6 cells/ml, and a titre of I/2O48 in haemagglutination tests with human group O erythrocytes. There was no visible cytotoxic effect when it was applied undiluted to monolayers of HEp-2 cells. The antiserum was inactivated at 560 for 3 ° min. and was used at a dilution of 1/32 in all experiments. Inhibition tests were made by comparing the number of plaques formed on 5 replicate monolayers of HEp-2 cells in 60 mm. diameter Petri dishes treated with 0"3 ml. of antiserum for t hr at 37 ° with those on 5 monolayers treated with serum at the same dilution from an unimmunized rabbit. The viruses used were prototype strains of enteroviruses with the exception of poliovirus type 2, for which the Sabin vaccine strain, OVP2, was used. Stocks of virus were propagated in HEp-2 cells. In the tests, 0-2 ml. of virus, diluted to give from 5o to IOO p.f.u, per monolayer, was inoculated on to each of 5 replicate cultures after the removal, without washing, of excess antiserum, and allowed to adsorb for I hr at 37 °. Plaques were counted after incubation for 3 days. In HEp-2 cells, as in amnion cells, antibody against the host cells had an inhibitory effect on the plaques formed by echoviruses but not those of poliovirus type 2 or Coxsackievirus B 6 (Table I ). Echovirus type I was chosen for further study because it gave large, clear plaques and because it showed strong inhibition. It was plaque-purified three times and repropagated in HEp-2 cells before use. In IO separate tests for inhibition of this virus, the reduction in plaque counts on cells treated with antiserum ranged from 74 to 98 % with a mean reduction of 84 %. Tests for neutralization of echovirus type t by the antiserum showed that the antiserum had no direct action on the virus. Virus was mixed with an equal volume of antiserum diluted I/8 for 1 hr at room temperature and the mixture was plated after being diluted I/IOO to dilute the antiserum above the highest titre at which inhibitory activity could be demonstrated. The mean plaque count after treatment of virus with antiserum was 63"4, which was not significantly different from the mean plaque count of 65"6 in a parallel experiment in which virus was treated with normal rabbit serum.
In human amnion cells, antibody to the host cells does not prevent adsorption of virus to cells but blocks some later stage in the virus growth cycle (Timbury, 1963) . It has therefore been suggested that the antiserum might induce the cells to produce interferon or some other inhibitory protein. This was investigated by studying the effect of actinomycin D on the inhibition of echovirus type I. Actinomycin D inhibits DNAcontrolled RNA synthesis by the host cells but does not affect the replication of RNA viruses (Reich et al. I96I) . The antibiotic inhibits the synthesis of interferon by cells (Heller, x963) and also prevents the virus-inhibiting action of interferon when it is added to cells (Taylor, I964) . In HEp-2 cells, addition of actinomycin D (I/zg./ml.) to the cells for r hr at 37 ° reduced the uptake of [aH] uridine by the cells by 78 %. Plaque formation, however, was variable in cells treated with the antibiotic at this t In this and Table 2 the statistical significance of all figures for percentage reduction in plaque counts was P = < o.ooi unless otherwise shown.
:~ Not statistically significant. § Actinomycin D (2 #g./ml.) was added to the medium of cultures for I hr before application of antiserum.
concentration and no plaques were seen in 3 of 6 attempted assays. When plaques did form they were of normal size but were fainter than those in untreated cells--largely due to poor staining of the background monolayer by the neutral red in the overlay. In the tests, actinomycin D was added to fresh medium in cultures of HEp-2 cells for I hr at 37 °, the cultures were washed once with phosphate buffered saline and antiserum and virus applied in the usual way. Actinomycin D did not prevent the inhibitory action of the antiserum (Table I ). Antiserum to the host cell does not therefore act by stimulating the cell to produce interferon or other inhibitory proteins.
As previously noted in amnion cells, the plaques formed on antiserum-treated monolayers of HEp-2 cells look the same as those on control cultures but are fewer. Virus from plaques in antiserum-treated monolayers was therefore tested to see if it differed from parental virus in susceptibility to the inhibitory effect of the antiserum. Single plaques were picked from those formed after one and after two passages in antiserum-treated monolayers. They were transferred to ampoules containing o'5 ml. phosphate buffered saline and stored at -70° . The samples were later thawed and after suitable dilution both lots of virus were tested at the same time for inhibition. Virus from plaques in antiserum-treated cells was as sensitive to the inhibition as the original virus (Table I ). The normal appearance of plaques in cells treated with antibody is therefore not due to the selection and growth of genetically resistant virus particles. The duration of the inhibitory effect was then investigated. If the action of the antiserum were transitory--for example, less than 6 hr--occasional cells which had escaped the action of the antiserum initially might become infected and release new virus which would be able to infect surrounding cells if the action of the antibody had worn off by the end of the first growth cycle. Inhibition tests were therefore made in monolayers treated with antiserum 7 2, 48 and 24 hr before inoculation of virus and were compared to tests in monolayers treated immediately before addition of virus. The antiserum was added for I hr at 37 ° in the usual way but after this the cultures were washed three times with phosphate buffered saline to prevent further reaction between antibody and cells and incubation was continued in fresh medium until the appropriate time for virus inoculation. Control cultures were treated in the same way with normal rabbit serum. Far from being transitory, the action of the antiserum was remarkably long-lasting and could be demonstrated up to 72 hr after its application and removal from the cells ( Table 2 ). The normal size of the plaques in antiserumtreated cells is therefore due neither to the emergence of resistant virus nor to the shortlived effect of the antiserum and remains an interesting but unexplained feature of the inhibition. 
